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We discuss the diagnosis of and eﬃcacy 5-amino-2-hydroxybenzoic acid (5-ASA), Saccharomyces boulardii, or magnesium in
therapy of microscopic colitis with presence of foamy macrophages. A basis for diagnosis and inclusion to the analysed group
was presence of characteristic foamy macrophages in histopathological examination of hematoxylin and eosin-stained specimens
collectedfromthelargeintestine,reviewedunder ×200or ×320magniﬁcation.Nostatisticallysigniﬁcantimprovementwasfound
following the use of 5-amino-2-dihydroxybenzoic acid in therapy of the disease. The use of Saccharomyces boulardii was associated
with statistically signiﬁcant improvement in clinical, endoscopic, and histopathological condition. Use of magnesium caused a
histological, statistically signiﬁcant improvement but failed to have any eﬀect on the clinical and endoscopic presentation. In the
group of children in whom no therapeutic intervention was provided, a statistically signiﬁcant spontaneous clinical improvement
was observed, but no statistically signiﬁcant changes in endoscopic and microscopic condition were found.
1.Introduction
Typical inﬂammatory bowel disease (IBD), such as ulcerative
colitis or Crohn’s disease, is only a part of cases of persistent
enteritis. Nonspeciﬁc IBDs are most often superﬁcial pro-
cesses, nondamaging to the structure of intestinal mucosa
and submucosa. In the medical literature, they are usually
referred to as microscopic enteritis [1–4].
Foamy colitis with presence of foamy macrophages
within the intestinal lamina propria belongs to a group of
microscopic inﬂammations in children. That recently sepa-
rated disease requires determination of eﬀective therapeutic
methods [5, 6].
Observation of that type of inﬂammation, indicating a
rather mild clinical course of the disease and no cases of
its transformation into a typical inﬂammatory bowel disease
(IBD) justiﬁed undertaking a prospective observation of
children treated with 5-amino-2-hydroxybenzoic acid,w i t ha
probiotic(Saccharomycesboulardii),orwithmagnesium,and
of a group of children who were not treated pharmacologi-
cally.
Evaluation of clinical, endoscopic, and microscopic ef-
fects of therapy with 5-amino-2-dihydroxybenzoic acid, Sac-
charomyces boulardii, or magnesium of children with micro-
scopic colitis with presence of foamy macrophages and
evaluation of a group of children with no therapeutic inter-
vention.
2.MaterialandMethods
A basis for diagnosis of the disease was presence of macro-
phages that stained with hematoxylin and eosin formed a
characteristicimageoffoamy(clearcell)macrophages,inthe
lamina propria of the large intestine.
Additional examinations using electron microscopy Jeol
100CX were performed in several cases. Sections of mucosa
were ﬁxed in cacodylate buﬀered 4% glutaraldehyde and
then in osmium tetroxide (OsO4) and analysed acc. to a
typical procedure for Epon. Resulting ultrathin sections were
additionally stained with lead citrate and uranyl acetate.
Uneven distribution and quantity of foamy macrophages
constituted a basis for development of our own classiﬁcation2 ISRN Gastroenterology
of microscopic changes, deﬁning three levels of intensity:
(i) single cells on various levels of the lamina propria,
(ii) presence of aggregates composed of 3–10 cells,
(iii) foamy cells covering evenly the whole lamina propria.
That type of cells was absent in other layers of the large
intestine, and their presence was not found in other sections
of the alimentary tract.
In the process of identiﬁcation of foamy macrophages,
except for hematoxylin and eosin staining of serial spec-
imens, also a PAS reaction was used, with and without
diastase digestion.
Additionally, immunocytochemical tests using mono-
clonal sera from DAKO: anti-CD3(T cell), CD4(T cell),
CD22 (B cell), CD31 (Endothelia), CD34 (precursor cell),
CD 68 (Macrophages), allowing identiﬁcation of cells occur-
ring in an inﬂammatory process, were completed on speci-
mens placed on hyalinized slides. Tests were also completed
to detect the PCNA-proliferation antigen, Ki67-mitotic
activity,chromogranin, synaptophysin, neuroﬁlament,actin,
P53 mutations, GFAP glial marker, TNF alpha, IL2, and
mucicarmin.
Tests were competed to detect intestinal pathogens (Sal-
monella, Shigella, Camphylobacter, Escherichia coli, Yersnia,
Clostridium diﬃcile) and Giardia infection.
Tests for enteroviruses were performed on cell lines (Hep
2 and RD) in the Department of Virusology of the National
Health Institute, using WHO-recommended methods. Pres-
ence of rotaviruses was tested with the latex reaction, using
the Slidex Rota-Kit, and completing serological tests with
ELISA, using Rabbit Anti-Rotavirus Human reagents from
DAKO.
Childrenwithpresenceoffoamymacrophagesconﬁrmed
in histopathological specimens and who had a clinical and
endoscopic changes characteristic for colitis were random-
ized to individual therapeutic groups of a prospective, open
trial realised from 1999 to 2009.
In the analysis, there were included 144 children aged
from 3 to 18 years. For 12 months, children received
5-amino-2-hydroxybenzoic acid (5-ASA) at dose of 20–
25mg/kg b.w./24h (38 children-group A), Saccharomyces
boulardii at dose of 15–20mg/kg b.w./24h (35 children-group
B), or magnesium 5–10mg/kg b.w./24h (35 children-group
D).
Childrenwhoreceivednotreatmentconstitutedacontrol
group (36 children-group C).
Clinical and endoscopic examinations were performed at
the Pediatric Ward, and microscopic and immunocytochem-
ical examinations—in the Department of Pathology in the
Children’s Memorial Health Institute in Warsaw.
Clinical evaluation included general feeling, presence of
abdominal pain and its intensity, number of bowel move-
ments per week, presence of blood in stool, fever, presence
of extraenteral symptoms, ESR, haemoglobin concentration,
and nutritional status expressed as Cole and Stanﬁeld index.
Clinical activity index (CAI) acc. to Rachmilewitz was
used for evaluation of clinical presentation of analysed
children [7].
The level of endoscopic lesions was determined by
evaluation of vascular pattern, granulation, and mucosa
proneness for bleeding, as well as presence of mucus, pus,
erosions, and ulcerations on the surface of colic mucosa. The
clinical activity index (CAI) acc. to Rachmilewitz was then
applied [7].
Evaluation of clinical and endoscopic changes was per-
formed at diagnosis and following 12 months of therapy and
observation of each analysed child.
Due to nonparametric distribution of sets, a sign test was
used for statistical evaluation of results (Statistica software).
3. Results and Discussion
At diagnosis, histopathological examination of bioptates
collected from the large intestine revealed presence of large,
clear, foamy cells in the lamina propria of the mucosa. Those
cells appeared single or in agglomerates, covering the whole
width of the lamina propria—from the covering epithelium
to the base of intestinal crypts and the level of muscularis
mucosa. (Figure 1)
Immunocytochemical tests indicated a strong positive
reaction with the CD68 antibody, typical for activated
macrophages. Foamy macrophages showed a positive PAS
reaction with periodic acid and Shiﬀ’s reagent. However,
the reaction was negative following digestion with dias-
tase. Immunocytochemical reaction to neuroﬁlament was
negative. Using the marker PCNA-proliferation antigen
an increased activity was demonstrated only in cryptic
epithelium. No increased activity was found in epithelium
surrounding crypts (Figure 2).
Other numerous, mentioned in the Methods section,
immunocytochemical markers gave a negative result in tests
with foamy macrophages (Table 1).
Before statistical analysis of results of clinical, endo-
scopic, and microscopic evaluation results for three study
groups, they were evaluated at the time of intervention.
Hypothesis of equality of those three groups (A, B, C, D) in
clinical, endoscopic, and microscopic evaluation cannot be
dismissed (Whitney-Mann test) (Figure 3).
In the group A, for 12 months, children received
Masalazine (5 amino-2-hydroxybenzoic acid). Clinical, endo-
scopic, and microscopic evaluation of the group A, treated
with 5-amino-2-hydroxybenzoic acid, showed no signiﬁcant
improvement, neither in clinical, endoscopic, nor in micro-
scopic presentation (Figure 4).
In the group B, Saccharomyces boulardii was used for 12
months. In the group B of children treated with Saccha-
romyces boulardii the 12-month period of therapy caused a
clinical, endoscopic, and microscopic, statistically signiﬁcant
improvement (Figure 5).
In the group C of children with microscopic colitis with
presence of foamy macrophages, no therapy was applied.
In the group C of untreated children the clinical
evaluation showed statistically signiﬁcant improvement, and
the endoscopic and microscopic evaluation showed no
regression of pathological lesions (Figure 6).
Children in the group D had magnesium administered
for 12 months. Statistical analysis of 12-month magnesiumISRN Gastroenterology 3
(a) (b) (c) (d)
Figure 1: (a–d) Microscopic features of colitis with presence of foamy macrophages—characteristic large, clear cells with a small nucleus,
single or aggregated within the lamina propria. HE staining. Magniﬁcation ×200.
(a) (b) (c) (d)
Figure 2: (a–d) Immunochemistry. (a-b) positive with a serum marking macrophages. C-negative to limfocytes T. D-neuroﬁlament’s
negative reaction. Magniﬁcation ×200 (a) ×320 (b, c, d).
Table 1:Expressionofimmunocytochemicalmarkersinthemicro-
scopic colitis with presence of foamy macrophages.
Macrophages foamy Marker
Negative CD3 (Cell T)
Negative CD4 (Cell T)
Negative CD22 (Cell B)
Negative CD34(Cell precursor)
Negative CD31 (Entothelial)
Positive CD68 (Macrophages)
Negative Ki67 mitotic activity
Negative Chromogranin
Negative Synaptophysin
Negative Neuroﬁlament
Negative Actin
Negative P53 mutations
Negative GFAP glial marker
Negative TNF alpha
Positive PAS
Positive Osmium tetraoxide
Negative IL2
Negative Mucicarmin
therapy shows microscopic and clinical improvement, but
without any endoscopic improvement. Microscopic diagno-
sis of that unspeciﬁc inﬂammatory disease is relatively easy
(Figure 7).
Presence of characteristic foamy macrophages observed
at ×200 and ×320 magniﬁcation in hematoxylin and eosin-
stained specimens is a crucial diagnostic factor [5, 6]. The
disease is not associated with destruction of glands or their
restructure. The lamina propria is not destroyed by lympho-
cytic inﬁltration, characteristic for inﬂammations belonging
to the group of IBD. Presence of foamy macrophages in
examined histopathological specimens excludes diagnosis of
Colitis ulcerosa or Crohn’s disease.
In IBD-type inﬂammations, proliferation of the mono-
nuclear-phagocytic line is characterised by a positive expres-
sion of TNF-alpha and IL-beta, absent in our examinations.
Microscopic evaluation of properly collected and prepared
specimens, but observed under a routinely used low magni-
ﬁcation, is a reason for underdiagnosis of the disease in other
centres.Observationofthewholegroupofchildrenconﬁrms
previous ﬁndings on mild and moderate course of that type
of inﬂammation [4, 6].
Children left without any therapeutic intervention show
no endoscopic or microscopic progression of lesions, and an
observedsurprisingclinicalimprovementindicatesanability
for independent regeneration of the intestine in that disease.
Existingreportsindicateeﬃcacyoftherapyofmildcolitis
with probiotics. Successful attempts were made in therapy
of ulcerative colitis and even of Crohn’s disease [8–12].
Part of favourable therapeutic eﬀects of monotherapy with
probiotics could be a result of erroneous qualiﬁcation of
microscopic colitis to a group of mild IBD. It seems that
probiotics may be useful as supplementary therapy, but their4 ISRN Gastroenterology
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Figure 3: Clinical, endoscopic, and microscopic evaluation at diagnosis (Whitney-Mann test).
use as a monotherapy is at least risky, particularly in the
Crohn’s disease.
A favourable clinical eﬀect of Saccharomyces boulardii
demonstrated in this trial, and conﬁrmed in control endo-
scopic and microscopic examinations, may be a result of a
trophic eﬀect of carbohydrates, B group vitamins (B1,B 2,B 6,
B12),folicacid,andpantoteicacidcontainedinthatprobiotic
on enterocytes [8].
Nicotinamide included in Saccharomyces boulardii may
reduce free oxygen radicals causing intensiﬁcation of the
inﬂammatory process, and numerous enzymes contained
there; for example, proteases and disaccharidases may causeISRN Gastroenterology 5
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Figure 4: Clinical, endoscopic, and microscopic evaluation of children treated with 5-amino-2-hydroxybenzoic acid (group A).
digestion of protein content of foamy macrophages and be
responsible for reduction of their count, demonstrated in
control microscopic examinations [8, 13].
A favourable therapeutic eﬀect of Saccharomyces bou-
lardii may be also a result of its conﬁrmed immunostimula-
tory and anti-inﬂammatory eﬀect, signiﬁcant for limitation
and reduction of the inﬂammatory process in the intestine
[13–15].
No favourable therapeutic eﬀect of 5-amino-2-dihydrox-
ybenzoic acid and relatively mild course of the disease jus-
tify resignation from therapy with Mesalazine (5-amino-2-
dihydroxybenzoic acid) in case of that type of colitis.
A favourable therapeutic eﬀect of magnesium, mani-
fested by regression of microscopic lesions, is most probably
a result of supplementation of magnesium deﬁciency, result-
ing from erosion of soil and low content of the element in6 ISRN Gastroenterology
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Figure 5: Clinical, endoscopic, and microscopic evaluation of children treated with Saccharomyces boulardii (group B).
food, and generally low level of supplementation. Besides,
mucosa defects found in colitis intensify magnesium deﬁ-
ciency through increased apoptosis.
Af a v o u r a b l ee ﬀect of magnesium treatment should be
probably associated with activating eﬀect of the element
on enzymes necessary for synthesis and utilisation of high-
energy compounds inside enterocytes. Further observation
seems important, expecting development of endoscopic
improvement. If it occurs, the microscopic improvement
should be treated as a herald of the endoscopic improve-
ment.
Systematic general paediatric and gastroenterological
control, along with monitoring of number of foamy macro-
phages in microscopic examination, plays a very important
role in diagnosis and therapy of that type of colitis [2]. The
suggested own scale for evaluation of microscopic changes
based on quantity of foamy macrophages in the lamina
propia shows a complete correlation with the clinical andISRN Gastroenterology 7
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Figure 6: Clinical, endoscopic, and microscopic evaluation of untreated children (group C).
endoscopic evaluation, when analysing the therapeutic eﬀect
of Saccharomyces boulardii and 5-amino-2-dihydroxybenzoic
acid and a correlation with the endoscopic presentation in
case of no therapeutic intervention.
Prospective clinical observation, periodical endoscopic
examinations of patients with that disease, will allow veri-
ﬁcation of currently available knowledge, and possibly will
open new diagnostic and therapeutic horizons. Diﬃculties
associated with unanimous classiﬁcation of a signiﬁcant
part of colitis to a strictly deﬁned group are a serious
medical problem [5, 16]. Classiﬁcation of chronic colitis
inadequate to actual condition may negatively inﬂuence
therapy and prognosis in this large, socially important group
of civilisation diseases.8 ISRN Gastroenterology
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Figure 7: Clinical, endoscopic, and microscopic evaluation of children treated with magnesium (group D).
4. Conclusions
(1) Presence of foamy macrophages within the lamina
propria of the large intestine is a deciding factor in
diagnosis of that form of microscopic colitis.
(2) Identiﬁcation of foamy macrophages is possible with
routine hematoxylin and eosin staining and micro-
scopic evaluation of histological specimens at ×200
or ×320 magniﬁcation.
(3) Eﬃcacy of Saccharomyces boulardii in therapy of mi-
croscopiccolitiswithpresenceoffoamymacrophages
was demonstrated.
(4) Nofavourabletherapeuticeﬀectwasachievedfollow-
ing use of 5-amino-2-dihydroxybenzoic acid (ASA-5)
in case of the disease.
(5) The disease shows a tendency for spontaneous remis-
sion, but only in terms of clinical presentation.ISRN Gastroenterology 9
(6) Microscopic and clinical improvement found in case
of magnesium therapy may be a herald of expected
endoscopic improvement.
(7) Further paediatric and gastroenterological followup
of children with that type of microscopic colitis is
necessary.
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